Search

Your search keyword '"VISCERAL leishmaniasis"' showing total 20,688 results

Search Constraints

Start Over You searched for: Descriptor "VISCERAL leishmaniasis" Remove constraint Descriptor: "VISCERAL leishmaniasis"
20,688 results on '"VISCERAL leishmaniasis"'

Search Results

301. LEYŞMANİOZ XƏSTƏLİYİNİN ÖYRƏNİLMƏ TARİXİ, KLİNİKASI VƏ TÖRƏDİCİLƏRİN MORFOLOGİYASI.

302. Coagulation Profile Alterations in Dogs Co-Infected with Visceral Leishmaniasis and Monocytic Ehrlichiosis.

303. Comparison of collection methods for Phlebotomus argentipes sand flies to use in a molecular xenomonitoring system for the surveillance of visceral leishmaniasis.

304. Diagnosis of visceral leishmaniasis in Ceará state, Brazil: A flow analysis of cases between 2007 and 2021.

305. Dogs with canine visceral leishmaniasis have a boost of extracellular vesicles and miR‐21‐5p up‐expression.

306. Accuracy of serological tests in diagnosing mucosal leishmaniasis.

307. Identification of potential inhibitors of Leishmania donovani Sterol 24-C- methyltransferase: in silico and in vitro studies.

308. Temporal trend in the incidence of human visceral leishmaniasis in Brazil.

309. Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent.

310. Visceral Leishmaniasis Caused by Leishmania Tropica.

311. Molecular Detection of Leishmania in Wild Caught Sand Flies of Larroussius Subgenus in Iran: Combined Use of Internal and External Morphological Characters as a Mean to Differentiate Morphologically Similar Females.

312. Coexistence of Cutaneous and Visceral Leishmaniasis in the Province of Moulay Yaâcoub, North-Central Morocco.

313. Mucosal Relapse of Visceral Leishmaniasis in a Child with SARS-CoV-2 Infection.

314. A Fatal Case of Disseminated Histoplasmosis by Histoplasma capsulatum var. capsulatum Misdiagnosed as Visceral Leishmaniasis—Molecular Diagnosis and Identification.

315. Metabolomics analysis of visceral leishmaniasis based on urine of golden hamsters.

316. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.

317. High seroprevalence of Leishmania infantum is linked to immune activation in people with HIV: a two-stage cross-sectional study in Bahia, Brazil.

318. Visceral leishmaniasis–human immunodeficiency virus coinfection in a 52-year-old male in southwest Iran: a case report.

319. Immunogenic mapping of rDyn-1 and rKDDR-plus proteins and selection of oligopeptides by immunoblotting for the diagnosis of Leishmania infantum-infected dogs.

320. Transmission dynamics of visceral leishmaniasis with PKDL and periodic delays.

321. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment.

322. Detection of Leishmania spp. in Cats: Analysis of Nasal, Oral and Conjunctival Swabs by PCR and HRM.

323. Co-infection of Leishmania infantum and a Crithidia-related species in a case of refractory relapsed visceral leishmaniasis with non-ulcerated cutaneous manifestation in Brazil.

324. Seroprevalence of Leishmania infantum in outdoor workers from southern Italian endemic regions.

325. Genetic variability highlights the invasion route of the Lutzomyia longipalpis complex, the main vector of Visceral Leishmaniasis in Uruguay.

326. Modeling and Analysis of a Fractional Visceral Leishmaniosis with Caputo and Caputo--Fabrizio derivatives.

327. Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis.

328. Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.

329. The Program for the Control of Visceral Leishmaniasis in Brazil: The Effect of the Systematic Euthanasia of Seropositive Dogs as a Single Control Action in Porteirinha, a Brazilian City with an Intense Transmission of Visceral Leishmaniasis.

330. Elucidating the role played by bone marrow in visceral leishmaniasis

331. The estimated distribution of autochthonous leishmaniasis by Leishmania infantum in Europe in 2005–2020.

332. Detection of Human Visceral Leishmaniasis Parasites in Microscopy Images from Bone Marrow Parasitological Examination.

333. Sero-prevalence of visceral leishmaniasis and its associated factors among asymptomatic individuals visiting Denan health center, southeastern Ethiopia.

334. Insights into Leishmania donovani potassium channel family and their biological functions.

335. Non-Vesicular Lipid Transport Machinery in Leishmania donovani : Functional Implications in Host-Parasite Interaction.

336. Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis.

337. Neurological Manifestation among Patients with Visceral Leishmaniasis at the Tropical Teaching Hospital - Khartoum.

338. Prevalence of Some Parasitic Infections in Iraq from 2019 to 2020.

339. Laryngeal leishmaniasis in a HIV-positive patient: A case report and review of the literature.

340. Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis.

341. Visceral Leishmaniasis in Iran: An Update on Epidemiological Features from 2013 to 2022.

342. Human Visceral Leishmaniasis: epidemiological monitoring and life indicators in municipalities in Bahia, Brazil.

343. Does the leishmaniasis protects against SARS-CoV-2.

344. Urine specific gravity as an indicator for the determination of urinary GGT in dogs with visceral leishmaniasis.

345. From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.

346. Factors associated with relapse and hospital death in patients coinfected with visceral leishmaniasis and HIV: a longitudinal study

347. Visceral leishmaniasis in new foci areas of Nepal: Sources and extent of infection

348. The Checklist and Distribution of Sand Flies (Diptera: Psychodidae) of Guilan Province and Their Medical Importance With a Taxonomic Note on the Name Sergentomyia murgabiensis sintoni

349. Massive vulval enlargement in a person living with HIV/AIDS: atypical presentation of cutaneous leishmaniasis.

350. Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach.

Catalog

Books, media, physical & digital resources